Roche unveils new STAT assays for cardiac biomarker testing

Justine Varieur Cadet | | Health Imaging | Diagnostic Imaging
Roche Diagnostics has introduced a new line of STAT immunoassays for cardiac biomarker testing on the cobas 6000 analyzer series, a system designed for diagnostic labs with medium testing volumes.

The nine-minute STAT immunoassay tests include troponin T, troponin I, CK-MB, myoglobin and NT-proBNP and run on the cobas e 601 analyzer, part of the cobas 6000 analyzer series, a platform that offers both clinical chemistry and immunoassay testing, according to the Indianapolis-based Roche.

Justine Varieur Cadet

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.